Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Angiocrine Bioscience Inc.

angiocrinebioscience.com

Latest From Angiocrine Bioscience Inc.

Finance Watch: Alternative Funding Sources Crucial Even Amidst A Biopharma VC Boom

Private Company Edition: Investments by CIRM, the GHIT fund and the European Investment Bank back early-stage science and treatments for neglected diseases. Also, Versant Ventures raises $700m in two funds. In VC deals, Akero raised $70m, Impel NeuroPharma brought in $67.5m.

Financing StartUps and SMEs
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
  • Therapeutic Areas
  • Immune Disorders
  • Musculoskeletal & Connective Tissue Disorders
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Angiocrine Bioscience Inc.
  • Senior Management
  • Paul Finnegan, MD, MBA, CEO
    Geoffrey C Davis, PhD, President & CSO
    John R Jaskowiak, VP, Corp Dev.
    Daniel J Nolan, PhD, Dir Research
  • Contact Info
  • Angiocrine Bioscience Inc.
    Phone: (646) 962-2436
    3750 Carmel Mountain Road
    Suite 200
    San Diego, CA 92130
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register